BiResp Spiromax Európska únia - slovenčina - EMA (European Medicines Agency)

biresp spiromax

teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - drogy obštrukčnej choroby dýchacích ciest, - asthma biresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdbiresp spiromax is indicated in adults, aged 18 years and older, for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).

DuoResp Spiromax Európska únia - slovenčina - EMA (European Medicines Agency)

duoresp spiromax

teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - drogy obštrukčnej choroby dýchacích ciest, - asthma duoresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdduoresp spiromax is indicated in adults, aged 18 years and older for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).

Trimbow Európska únia - slovenčina - EMA (European Medicines Agency)

trimbow

chiesi farmaceutici s.p.a. - beclometasone dipropionate, formoterol fumarate disodný, glycopyrronium bromid - pľúcna choroba, chronická obštrukcia - drogy obštrukčnej choroby dýchacích ciest, - maintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and high dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year. copdmaintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2-agonist or a combination of a long-acting beta2-agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5. asthmamaintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and medium dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year.

Riarify (previously CHF 5993 Chiesi Farmaceutici S.p.A.) Európska únia - slovenčina - EMA (European Medicines Agency)

riarify (previously chf 5993 chiesi farmaceutici s.p.a.)

chiesi farmaceutici s.p.a. - formoterol fumarate dihydrate, glycopyrronium, beclometasone dipropionate - pľúcna choroba, chronická obštrukcia - drogy obštrukčnej choroby dýchacích ciest, - udržiavacia liečba u dospelých pacientov so stredne závažnou až závažnou chronickou obštrukčnou chorobou pľúc (chochp), ktorí nie sú dostatočne liečení kombináciou inhalačného kortikosteroidu a dlhodobo pôsobiaci beta2-agonista (pre ovplyvnenie príznakov a prevencie exacerbácií pozri časť 5.

Trydonis Európska únia - slovenčina - EMA (European Medicines Agency)

trydonis

chiesi farmaceutici s.p.a. - beclometasone dipropionate, formoterol fumarate disodný, glycopyrronium - pľúcna choroba, chronická obštrukcia - drogy obštrukčnej choroby dýchacích ciest, - udržiavacia liečba u dospelých pacientov so stredne závažnou až závažnou chronickou obštrukčnou chorobou pľúc (chochp), ktorí nie sú dostatočne liečení kombináciou inhalačného kortikosteroidu a dlhodobo pôsobiaci beta2-agonista (pre ovplyvnenie príznakov a prevencie exacerbácií pozri časť 5.

Enap Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

enap

krka, d.d., novo mesto, slovinsko - enalapril - 58 - hypotensiva

Enap H Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

enap h

krka, d.d., novo mesto, slovinsko - enalapril a diuretiká - 58 - hypotensiva

RANISAN 150 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

ranisan 150 mg

pro.med.cs praha a.s., Česká republika - ranitidín - 09 - antacida (vrÁtane antiulcerosnych lieČiv)

RANITAL 50 mg/2 ml Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

ranital 50 mg/2 ml

sandoz pharmaceuticals d.d., slovinsko - ranitidín - 09 - antacida (vrÁtane antiulcerosnych lieČiv)

RANITAL 150 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

ranital 150 mg

sandoz pharmaceuticals d.d., slovinsko - ranitidín - 09 - antacida (vrÁtane antiulcerosnych lieČiv)